Profil
Michael M.
Moore worked as a Director of Research and Development & Operations at Medtronic, Inc. and as a Vice President of Operations at Velomedix, Inc. He was also a Chief Technical Officer at Bolton Medical, Inc. from 2008 to 2008 and a Vice President of Operations at Clearpoint Neuro, Inc. Mr. Moore received his undergraduate degree from Purdue University.
Anciens postes connus de Michael M. Moore
| Sociétés | Poste | Fin |
|---|---|---|
Bolton Medical, Inc.
 Bolton Medical, Inc. Medical SpecialtiesHealth Technology Bolton Medical is a leading provider of endovascular solutions for aortic disease based in Miami, US, with 45 million Euros in sales and over 300 employees. Devoted to improve the quality and safety in patient care by developing, manufacturing, and distributing innovative, high quality products and technology solely focused on the aorta to include TAA, AAA, and custom made stent graft systems. | Directeur Technique/Scientifique/R&D | 02/03/2008 |
Velomedix, Inc.
 Velomedix, Inc. Medical SpecialtiesHealth Technology Velomedix is a development stage medical device company created to realize the clinical potential of mild therapeutic hypothermia in benefiting patients suffering from ischemic and reperfusion injury effects of cardiac arrest, heart attack, stroke and traumatic brain injury. A comprehensive review of the medical literature demonstrates that cooling protects cells at risk, prevents tissue death and preserves organ function. Therapeutic Hypothermia offers a novel solution for the protection of the body's organs during ischemic insults and later from reperfusion injury. Cooling protects tissue during ischemia by reducing oxygen metabolism, inflammation and maintaining cell membrane integrity. In the case of reperfusion injury hypothermia reduces oxidative stress, micro vascular clogging, free radical production and inflammatory responses which are destructive to cells that have had blood flow restored after a period of ischemia. | Directeur des opérations | - |
Medtronic, Inc.
 Medtronic, Inc. Medical SpecialtiesHealth Technology Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN. | Directeur Technique/Scientifique/R&D | - |
| CLEARPOINT NEURO, INC. | Directeur des opérations | 20/07/2010 |
Formation de Michael M. Moore
| Purdue University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CLEARPOINT NEURO, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Bolton Medical, Inc.
Bolton Medical, Inc. Medical SpecialtiesHealth Technology Bolton Medical is a leading provider of endovascular solutions for aortic disease based in Miami, US, with 45 million Euros in sales and over 300 employees. Devoted to improve the quality and safety in patient care by developing, manufacturing, and distributing innovative, high quality products and technology solely focused on the aorta to include TAA, AAA, and custom made stent graft systems. | Health Technology |
Medtronic, Inc.
Medtronic, Inc. Medical SpecialtiesHealth Technology Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN. | Health Technology |
Velomedix, Inc.
Velomedix, Inc. Medical SpecialtiesHealth Technology Velomedix is a development stage medical device company created to realize the clinical potential of mild therapeutic hypothermia in benefiting patients suffering from ischemic and reperfusion injury effects of cardiac arrest, heart attack, stroke and traumatic brain injury. A comprehensive review of the medical literature demonstrates that cooling protects cells at risk, prevents tissue death and preserves organ function. Therapeutic Hypothermia offers a novel solution for the protection of the body's organs during ischemic insults and later from reperfusion injury. Cooling protects tissue during ischemia by reducing oxygen metabolism, inflammation and maintaining cell membrane integrity. In the case of reperfusion injury hypothermia reduces oxidative stress, micro vascular clogging, free radical production and inflammatory responses which are destructive to cells that have had blood flow restored after a period of ischemia. | Health Technology |